Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Garsorasib [inn]
2. 2559761-14-5
3. P491ne9g6z
4. Unii-p491ne9g6z
5. 4-((2s,5r)-4-acryloyl-2,5-dimethylpiperazin-1-yl)-7-(2-amino-6-fluorophenyl)-1-(4,6-dicyclopropylpyrimidin-5-yl)-6-fluoropyrido(2,3-d)pyrimidin-2(1h)-one
6. D-1553
7. Pyrido(2,3-d)pyrimidin-2(1h)-one, 7-(2-amino-6-fluorophenyl)-1-(4,6-dicyclopropyl-5-pyrimidinyl)-4-((2s,5r)-2,5-dimethyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl)-6-fluoro-
8. Garsorasib [who-dd]
9. Chembl5095066
10. Schembl22704797
11. Glxc-26938
12. Ex-a5695
13. Akos040757847
14. Ms-30601
15. Hy-145571
16. Cs-0376098
17. D 1553
18. 7-(2-amino-6-fluorophenyl)-1-(4,6-dicyclopropylpyrimidin-5-yl)-4-[(2s,5r)-2,5-dimethyl-4-prop-2-enoylpiperazin-1-yl]-6-fluoropyrido[2,3-d]pyrimidin-2-one
| Molecular Weight | 598.6 g/mol |
|---|---|
| Molecular Formula | C32H32F2N8O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 121 |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1150 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
11
PharmaCompass offers a list of Garsorasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Garsorasib manufacturer or Garsorasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Garsorasib manufacturer or Garsorasib supplier.
PharmaCompass also assists you with knowing the Garsorasib API Price utilized in the formulation of products. Garsorasib API Price is not always fixed or binding as the Garsorasib Price is obtained through a variety of data sources. The Garsorasib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HY-145571 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HY-145571, including repackagers and relabelers. The FDA regulates HY-145571 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HY-145571 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HY-145571 supplier is an individual or a company that provides HY-145571 active pharmaceutical ingredient (API) or HY-145571 finished formulations upon request. The HY-145571 suppliers may include HY-145571 API manufacturers, exporters, distributors and traders.
HY-145571 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HY-145571 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HY-145571 GMP manufacturer or HY-145571 GMP API supplier for your needs.
A HY-145571 CoA (Certificate of Analysis) is a formal document that attests to HY-145571's compliance with HY-145571 specifications and serves as a tool for batch-level quality control.
HY-145571 CoA mostly includes findings from lab analyses of a specific batch. For each HY-145571 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HY-145571 may be tested according to a variety of international standards, such as European Pharmacopoeia (HY-145571 EP), HY-145571 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HY-145571 USP).
